An W, Lakhina S, Leong J, Rawat K, Husain M
Pathogens. 2024; 13(7).
PMID: 39057788
PMC: 11280125.
DOI: 10.3390/pathogens13070561.
Yang Y, Furzer O, Fensterle E, Lin S, Zheng Z, Kim N
Science. 2024; 383(6684):eadk3468.
PMID: 38359131
PMC: 11298796.
DOI: 10.1126/science.adk3468.
Jiang R, Zhu W, Liao Z, Yang C, Su J
iScience. 2023; 26(12):108315.
PMID: 38025781
PMC: 10679900.
DOI: 10.1016/j.isci.2023.108315.
Maes S, Deploey N, Peelman F, Eyckerman S
Cell Rep Methods. 2023; 3(11):100641.
PMID: 37963462
PMC: 10694495.
DOI: 10.1016/j.crmeth.2023.100641.
Minderman M, Lantermans H, van der Zwaan C, Hoogendijk A, van den Biggelaar M, Kersten M
Blood Cancer J. 2023; 13(1):125.
PMID: 37591861
PMC: 10435502.
DOI: 10.1038/s41408-023-00896-6.
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-B pathway.
Yoon S, Hong H, Lim H, Choi J, Choi Y, Seo S
Acta Pharm Sin B. 2023; 13(3):1093-1109.
PMID: 36970199
PMC: 10031381.
DOI: 10.1016/j.apsb.2022.12.001.
Human and Bacterial Toll-Interleukin Receptor Domains Exhibit Distinct Dynamic Features and Functions.
Lee E, Redzic J, Nemkov T, Saviola A, Dzieciatkowska M, Hansen K
Molecules. 2022; 27(14).
PMID: 35889366
PMC: 9318647.
DOI: 10.3390/molecules27144494.
Structural basis of the IL-1 receptor TIR domain-mediated IL-1 signaling.
Zhou J, Xiao Y, Ren Y, Ge J, Wang X
iScience. 2022; 25(7):104508.
PMID: 35754719
PMC: 9213720.
DOI: 10.1016/j.isci.2022.104508.
Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy.
Xie B, Luo A
Front Cell Dev Biol. 2022; 10:903781.
PMID: 35557952
PMC: 9089908.
DOI: 10.3389/fcell.2022.903781.
Discovery of a Novel MyD88 Inhibitor M20 and Its Protection Against Sepsis-Mediated Acute Lung Injury.
Song J, Chen D, Pan Y, Shi X, Liu Q, Lu X
Front Pharmacol. 2021; 12:775117.
PMID: 34912226
PMC: 8666603.
DOI: 10.3389/fphar.2021.775117.
Heterologous Expression and Assembly of Human TLR Signaling Components in .
Coronas-Serna J, Del Val E, Kagan J, Molina M, Cid V
Biomolecules. 2021; 11(11).
PMID: 34827735
PMC: 8615643.
DOI: 10.3390/biom11111737.
Modulation of Toll-like receptor 1 intracellular domain structure and activity by Zn ions.
Lushpa V, Goncharuk M, Lin C, Zalevsky A, Talyzina I, Luginina A
Commun Biol. 2021; 4(1):1003.
PMID: 34429510
PMC: 8385042.
DOI: 10.1038/s42003-021-02532-0.
MyD88 TIR domain higher-order assembly interactions revealed by microcrystal electron diffraction and serial femtosecond crystallography.
Clabbers M, Holmes S, Muusse T, Vajjhala P, Thygesen S, Malde A
Nat Commun. 2021; 12(1):2578.
PMID: 33972532
PMC: 8110528.
DOI: 10.1038/s41467-021-22590-6.
Dinoflagellate symbionts escape vomocytosis by host cell immune suppression.
Jacobovitz M, Rupp S, Voss P, Maegele I, Gornik S, Guse A
Nat Microbiol. 2021; 6(6):769-782.
PMID: 33927382
PMC: 7611106.
DOI: 10.1038/s41564-021-00897-w.
Structure of the activated ROQ1 resistosome directly recognizing the pathogen effector XopQ.
Martin R, Qi T, Zhang H, Liu F, King M, Toth C
Science. 2020; 370(6521).
PMID: 33273074
PMC: 7995448.
DOI: 10.1126/science.abd9993.
Innate Immune Sensing of Influenza A Virus.
Malik G, Zhou Y
Viruses. 2020; 12(7).
PMID: 32674269
PMC: 7411791.
DOI: 10.3390/v12070755.
A Computational Probe into the Structure and Dynamics of the Full-Length Toll-Like Receptor 3 in a Phospholipid Bilayer.
Patra M, Batool M, Haseeb M, Choi S
Int J Mol Sci. 2020; 21(8).
PMID: 32325904
PMC: 7215789.
DOI: 10.3390/ijms21082857.
Negative Regulation of TLR Signaling by BCAP Requires Dimerization of Its DBB Domain.
Lauenstein J, Scherm M, Udgata A, Moncrieffe M, Fisher D, Gay N
J Immunol. 2020; 204(8):2269-2276.
PMID: 32198144
PMC: 7128310.
DOI: 10.4049/jimmunol.1901210.
A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models.
Achek A, Kwon H, Patra M, Shah M, Hong R, Lee W
EBioMedicine. 2020; 52:102645.
PMID: 32014819
PMC: 6997517.
DOI: 10.1016/j.ebiom.2020.102645.
MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling.
Moncrieffe M, Bollschweiler D, Li B, Penczek P, Hopkins L, Bryant C
Structure. 2020; 28(3):281-289.e3.
PMID: 31995744
PMC: 7054835.
DOI: 10.1016/j.str.2020.01.003.